{{Rsnum
|rsid=7937
|Gene=RAB4B-EGLN2
|Chromosome=19
|position=40796801
|Orientation=plus
|GMAF=0.4816
|Gene_s=MIA-RAB4B,RAB4B,RAB4B-EGLN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.6 | 52.2 | 29.2
| HCB | 12.4 | 47.4 | 40.1
| JPT | 10.7 | 37.5 | 51.8
| YRI | 66.0 | 29.9 | 4.2
| ASW | 43.9 | 38.6 | 17.5
| CHB | 12.4 | 47.4 | 40.1
| CHD | 10.1 | 45.0 | 45.0
| GIH | 36.0 | 45.0 | 19.0
| LWK | 48.2 | 45.5 | 6.4
| MEX | 19.3 | 42.1 | 38.6
| MKK | 30.8 | 56.4 | 12.8
| TSI | 19.6 | 46.1 | 34.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=22080838
|Title=A Genome-Wide Association Study of COPD Identifies a Susceptibility Locus on Chromosome 19q13
|OA=1
}}

{{PMID Auto
|PMID=16451668
|Title=Application of the regression of offspring on mid-parent method to detect associations between single-nucleotide polymorphisms and the beta 2 electroencephalogram phenotype in the COGA data.
|OA=1
}}

{{PMID Auto
|PMID=21862624
|Title=Genetic polymorphisms in 15q25 and 19q13 loci, cotinine levels, and risk of lung cancer in EPIC.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}